Bajaj Healthcare Limited (BAJAJHCARE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has a cash flow conversion efficiency ratio of 0.042x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs133.20 Million ≈ $1.44 Million USD) by net assets (Rs3.16 Billion ≈ $34.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bajaj Healthcare Limited - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Bajaj Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BAJAJHCARE current and long-term liabilities for a breakdown of total debt and financial obligations.
Bajaj Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bajaj Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gandhi Special Tubes Limited
NSE:GANDHITUBE
|
0.090x |
|
Bcl Industries Limited
NSE:BCLIND
|
0.021x |
|
ReFuels N.V.
OL:REFL
|
N/A |
|
Siam Pan Group PCL
BK:SPG
|
0.014x |
|
Action SA
WAR:ACT
|
-0.060x |
|
Axcen Photonics
TWO:6530
|
0.021x |
|
DreamCIS Inc
KQ:223250
|
0.023x |
|
Cti Logistics Ltd
AU:CLX
|
0.214x |
Annual Cash Flow Conversion Efficiency for Bajaj Healthcare Limited (2011–2025)
The table below shows the annual cash flow conversion efficiency of Bajaj Healthcare Limited from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Bajaj Healthcare Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs4.66 Billion ≈ $50.41 Million |
Rs-57.78 Million ≈ $-624.87K |
-0.012x | -103.74% |
| 2024-03-31 | Rs2.78 Billion ≈ $30.10 Million |
Rs922.94 Million ≈ $9.98 Million |
0.332x | +646.11% |
| 2023-03-31 | Rs3.68 Billion ≈ $39.76 Million |
Rs-223.24 Million ≈ $-2.41 Million |
-0.061x | -3007.22% |
| 2022-03-31 | Rs3.28 Billion ≈ $35.52 Million |
Rs6.86 Million ≈ $74.19K |
0.002x | -98.76% |
| 2021-03-31 | Rs2.58 Billion ≈ $27.95 Million |
Rs435.58 Million ≈ $4.71 Million |
0.169x | +24.21% |
| 2020-03-31 | Rs1.52 Billion ≈ $16.40 Million |
Rs205.75 Million ≈ $2.23 Million |
0.136x | -30.38% |
| 2019-03-31 | Rs1.29 Billion ≈ $13.96 Million |
Rs251.69 Million ≈ $2.72 Million |
0.195x | +33.31% |
| 2018-03-31 | Rs1.14 Billion ≈ $12.29 Million |
Rs166.14 Million ≈ $1.80 Million |
0.146x | -37.16% |
| 2017-03-31 | Rs990.00 Million ≈ $10.71 Million |
Rs230.39 Million ≈ $2.49 Million |
0.233x | -17.95% |
| 2016-03-31 | Rs886.32 Million ≈ $9.59 Million |
Rs251.38 Million ≈ $2.72 Million |
0.284x | -60.35% |
| 2015-03-31 | Rs390.72 Million ≈ $4.23 Million |
Rs279.51 Million ≈ $3.02 Million |
0.715x | +29.24% |
| 2014-03-31 | Rs315.57 Million ≈ $3.41 Million |
Rs174.68 Million ≈ $1.89 Million |
0.554x | +12.94% |
| 2013-03-31 | Rs295.85 Million ≈ $3.20 Million |
Rs145.00 Million ≈ $1.57 Million |
0.490x | +74.79% |
| 2012-03-31 | Rs306.41 Million ≈ $3.31 Million |
Rs85.92 Million ≈ $929.15K |
0.280x | +86.89% |
| 2011-03-31 | Rs299.91 Million ≈ $3.24 Million |
Rs44.99 Million ≈ $486.60K |
0.150x | -- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more